Back to Search
Start Over
Sepracor reports preliminary Ph II SEP-225441 results in GAD
- Source :
- Pharma Marketletter. March 16, 2009
- Publication Year :
- 2009
-
Abstract
- USA firm Sepracor has completed the analysis and validation of the preliminary results of a Phase II, 440-patient study evaluating the efficacy and safety of SEP-225441, a modified-release formulation of [...]
Details
- Language :
- English
- ISSN :
- 13558501
- Database :
- Gale General OneFile
- Journal :
- Pharma Marketletter
- Publication Type :
- News
- Accession number :
- edsgcl.196446855